Enantioselective Box Behenken Optimized HPLC-DAD Method for the Simultaneous Estimation of Alogliptin Enantiomorphs in Pharmaceutical For mulations and their Pharmacokinetic Study in Rat Plasma

Enantioselective Box Behenken Optimized HPLC-DAD Method for the Simultaneous Estimation of Alogliptin Enantiomorphs in Pharmaceutical For mulations and their Pharmacokinetic Study in Rat Plasma

Purpose: A stereoselective high performance liquid chromatographic analytical method withphotodiode array detector was developed and validated as per the International Conferenceon Harmonization (ICH) guidelines for the determination of alogliptin (ALO) enantiomers informulations and rat plasma.Meth...

Full description

Bibliographic Details
Main Authors:	Ravi Kant, Ramesh Babu Bodla, Rubina Bhutani, Garima Kapoor
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2019-02-01
Series:	Advanced Pharmaceutical Bulletin
Subjects:	Alogliptin enantiomers Box–Behnken Design Pharmacokinetics HPLC-DAD SPE
Online Access:	https://apb.tbzmed.ac.ir/PDF/apb-20690

Similar Items

Salting-out induced liquid–liquid microextraction for alogliptin benzoate determination in human plasma by HPLC/UV
by: Sherin F. Hammad, et al.
Published: (2021-01-01)

CARDIOVASCULAR SAFETY OF GLIPTINS. FOCUS ON ALOGLIPTIN
by: N. A. Petunina, et al.
Published: (2017-12-01)

A developed HPLC method for the determination of Alogliptin Benzoate and its potential impurities in bulk drug and tablets
by: Kun Zhang, et al.
Published: (2015-04-01)

PREDICTION OF ANTI-DIABETIC ALOGLIPTIN STABILITY BY ISOTHERMAL STUDIES
by: Charise Dallazem Bertol, et al.
Published: (2023-10-01)

Mechanistic insights toward progress in alogliptin beyond glycemic control: translational perspective
by: Faraha Ahmed, et al.
Published: (2025-02-01)

A Validated Ultrasound-Assisted Extraction Coupled with SPE-HPLC-DAD for the Determination of Flavonoids in By-Products of Plant Origin: An Application Study for the Valorization of the Walnut Septum Membrane
by: Natasa P. Kalogiouri, et al.
Published: (2021-10-01)

Formulation and Optimization of Alogliptin-Loaded Polymeric Nanoparticles: In Vitro to In Vivo Assessment
by: Dibyalochan Mohanty, et al.
Published: (2022-07-01)

Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment
by: M. V. Shestakova, et al.
Published: (2021-07-01)

Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial
by: João Pedro Ferreira, et al.
Published: (2020-06-01)

Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS
by: Anna Petruczynik, et al.
Published: (2020-05-01)

Synthesis of a novel analogue of DPP-4 inhibitor Alogliptin: Introduction of a spirocyclic moiety on the piperidine ring
by: Arumugam Kodimuthali, et al.
Published: (2010-07-01)

Alogliptin – the new member of DPP-4 inhibitors class
by: Nina Aleksandrovna Petunina, et al.
Published: (2014-12-01)

Optimization and development of SPE-HPLC-DAD method for the determination of atrazine, malathion, fenitrothion and parathion pesticide residues in apple juice
by: Lenche Velkoska-Markovska, et al.
Published: (2013-12-01)

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
by: Hae Jin Kim, et al.
Published: (2022-09-01)

Utility of picric acid and 2,4 dinitrophenol as chromogenic reagents for visible spectrophotometric quantification of alogliptin
by: A.V.V.N.K. Sunil Kumar, et al.
Published: (2017-06-01)

Alogliptin: efficiency, safety, new possibilities
by: L. Yu. Morgunov
Published: (2020-05-01)

Combining HPLC-DAD-QTOF-MS and HPLC-SPE-NMR to Monitor In Vitro Vitetrifolin D Phase I and II Metabolism
by: Sonja Sturm, et al.
Published: (2021-08-01)

Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes
by: Xu Liu, et al.
Published: (2021-09-01)

HILIC-DAD Method for Simultaneous Determination of Acid and Basic Drugs: Application to the Quantitation of Ibuprofen, Atenolol, and Salbutamol in Urine After Solid-Phase Extraction
by: Noelia Rosales-Conrado, et al.
Published: (2025-01-01)

Investigation of Alogliptin-Loaded In Situ Gel Implants by 2<sup>3</sup> Factorial Design with Glycemic Assessment in Rats
by: Tarek M. Ibrahim, et al.
Published: (2022-09-01)

Development and Validation of HPLC-DAD and UHPLC-DAD Methods for the Simultaneous Determination of Guanylhydrazone Derivatives Employing a Factorial Design
by: Wanessa Azevedo de Brito, et al.
Published: (2017-08-01)

Reliable choice in therapy of type 2 diabetes mellitus: focus on alogliptin
by: N. A. Petunina, et al.
Published: (2019-01-01)

Remitting Seronegative Symmetrical Synovitis and Pitting Edema Syndrome After Administration of a Dipeptidyl Peptidase-4 Inhibitor, Alogliptin, in a Patient With Type 2 Diabetes
by: Shota Mochizuki, et al.
Published: (2022-07-01)

MODERN POSSIBILITIES OF THERAPY OF TYPE 2 DIABETES MELLITUS PATIENTS. EFFECTIVENESS AND CARDIOSAFETY OF ALOGLIPTIN FROM THE POINT OF VIEW OF EVIDENCE-BASED MEDICINE
by: A. S. Ametov, et al.
Published: (2017-07-01)

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report
by: Noda Yoko, et al.
Published: (2013-01-01)

Simultaneous Determination of Isothiazolinones and Parabens in Cosmetic Products Using Solid-Phase Extraction and Ultra-High Performance Liquid Chromatography/Diode Array Detector
by: Hazim Mohammed Ali, et al.
Published: (2020-11-01)

Optimization of the experimental parameters of fluticasone propionate microparticles for pulmonary delivery using a box behenken design
by: P V Patel, et al.
Published: (2012-01-01)

HPLC-DAD
by: Dina A. Gawad, et al.
Published: (2017-05-01)

Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial
by: Ji-Yeon Park, et al.
Published: (2024-09-01)

Influence of tannin addition on the content and composition of polyphenolic compounds in wines
by: Marie CÍCHOVÁ, et al.
Published: (2008-12-01)

Determination of maleic hydrazide residues in onion
by: Bursić Vojislava, et al.
Published: (2010-01-01)

Environmental behavior of the chiral fungicide epoxiconazole in earthworm-soil system: Enantioselective enrichment, degradation kinetics, chiral metabolite identification, and biotransformation mechanism
by: Pengfei Xue, et al.
Published: (2022-09-01)

Enantioselective chemical synthesis : methods, logic and practice /
by: Corey, E. J., author, et al.
Published: (2010)

Stability-indicating HPLC-DAD method for the determination of empagliflozin
by: Shilpi Pathak, et al.
Published: (2021-08-01)

Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DAD
by: Cesar Filho, et al.
Published: (2022-04-01)

Fast and selective HPLC-DAD method for determination of pholcodine and related substances
by: Ana Petkovska, et al.
Published: (2011-12-01)

Cardiovascular safety in the treatment of diabetes mellitus type 2: focus on alogliptin
by: A. L. Terekhova, et al.
Published: (2016-12-01)

Economic effectiveness of fixed-dose combination of alogliptin and pioglitazone in diabetes mellitus treatment
by: S. К. Zyryanov, et al.
Published: (2025-02-01)

Comparison of reversed-phase enantioselective HPLC methods for determining the enantiomeric purity of (S)-omeprazole in the presence of its related substances
by: Bruno Gallinella, et al.
Published: (2016-04-01)

HPLC-DAD-ESI-MSn identification of phenolic compounds in cultivated strawberries from Macedonia
by: Marina Kajdžanoska, et al.
Published: (2010-12-01)